VolitionRx Limited Announces Full Fiscal Year 2022 Financial Results and Business Update

Conference call to discuss financial and operational results scheduled for Thursday, March 16, at 8:30 a.m. U.S. Eastern Time Executed global licensing and...

Related Keywords

United States ,Canada ,United Kingdom ,France ,London ,City Of ,Singapore ,Belgium ,America ,American ,Louise Batchelor Debra Daglish ,Scott Powell ,Cameron Reynolds ,Tom Butera ,Terig Hughes ,Breakthrough Device Program ,American Company Guide Section ,Exchange Commission On ,Volition Veterinary Diagnostics Development ,National Taiwan University Lung ,Exchange Commission ,Volitionrx Limited Full Fiscal ,Toll International ,Information Technology ,Securities Exchange ,European Society Of Veterinary Oncology Congress ,Heska Licensing ,Namur Invest Capital Risk ,Human Resources ,Vet Cancer Test ,Canine Cancer Screen ,Monitor Test ,Vet Product ,European Society ,Veterinary Oncology Congress ,Sequential Organ Failure Assessment ,Device Program ,Hospices Civils De Lyon ,Lyonnaise Initiative ,Lung Cancer Screening ,Group Chief Executive Officer ,Group Chief Financial Officer ,Chief Executive Officer ,Executive Vice President ,Investor Relations ,Capital Market Day ,Debra Daglish ,Securities Act ,Securities Exchange Act ,Annual Report ,Quarterly Reports ,Company Guide Section ,Volitionrx Limited ,